Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data.

Published in: Journal of psychopharmacology (Oxford, England) (2021)

Although flumazenil shows promising efficacy in the management of benzodiazepine use disorders and withdrawal, more randomized control trials are required before a definitive recommendation can be made around its use.

Keyphrases

double blind
open label
electronic health record
placebo controlled
big data
randomized controlled trial
squamous cell carcinoma
phase ii
radiation therapy
artificial intelligence